Pharma MNCs Eye Chinese Generics Makers, Says GSK China CEO
This article was originally published in PharmAsia News
Executive Summary
John Lepore, vice president and general manager of China for GlaxoSmithKline PLC, said that in preparation for the upcoming increase in generics competition, some multinational drug companies in China have accelerated acquiring domestic generic producers.